Top Markets
Coin of the day
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.

Claritas Pharmaceuticals, Inc.

CLAZF
Rangering i aksjer #42176
Operating as a clinical-stage specialty pharmaceutical entity, Claritas... Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$3.66K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Claritas Pharmaceuticals, Inc. (CLAZF)

Kategori

P/S-forhold for Claritas Pharmaceuticals, Inc. (CLAZF)
P/S-forhold per 2026 TTM: 0
Ifølge Claritas Pharmaceuticals, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Claritas Pharmaceuticals, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR